Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients (Q44441505)

3 December 2017

title

Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients (English)

1 reference

3 December 2017

0 references

1 reference

cytomegaloviral disease

1 reference

J A Khoury

1

1 reference

3 December 2017

G A Storch

2

1 reference

3 December 2017

D L Bohl

3

1 reference

3 December 2017

R M Schuessler

4

1 reference

3 December 2017

S M Torrence

5

1 reference

3 December 2017

M Lockwood

6

1 reference

3 December 2017

M Gaudreault-Keener

7

1 reference

3 December 2017

M J Koch

8

1 reference

3 December 2017

B W Miller

9

1 reference

3 December 2017

K L Hardinger

10

1 reference

3 December 2017

M A Schnitzler

11

1 reference

3 December 2017

D C Brennan

12

1 reference

3 December 2017

language of work or name

English

0 references

publication date

19 June 2006

1 reference

American Journal of Transplantation

3 December 2017

published in

1 reference

3 December 2017

volume

6

1 reference

3 December 2017

issue

9

1 reference

3 December 2017

page(s)

2134-2143

1 reference

Management of cytomegalovirus infection by weekly surveillance after renal transplant: analysis of cost, rejection and renal function

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01413.X

Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01413.X

Prophylaxis for CMV should not now replace pre-emptive therapy in solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01413.X

Late-onset cytomegalovirus disease as a significant complication in solid organ transplant recipients receiving antiviral prophylaxis: a call to heed the mounting evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01413.X

Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01413.X

Single-dose pharmacokinetics of valganciclovir in HIV- and CMV-seropositive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01413.X

Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01413.X

Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01413.X

Kinetics of cytomegalovirus load decrease in solid-organ transplant recipients after preemptive therapy with valganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01413.X

A prospective assessment of valganciclovir for the treatment of cytomegalovirus infection and disease in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01413.X

Multiplex, quantitative, real-time PCR assay for cytomegalovirus and human DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01413.X

Human cytomegalovirus resistance to antiviral drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01413.X

The Association of Cytomegalovirus Sero-Pairing with Outcomes and Costs Following Cadaveric Renal Transplantation Prior to the Introduction of Oral Ganciclovir CMV Prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01413.X

Definitions of cytomegalovirus infection and disease in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01413.X

CMV infection of the renal allograft is much more common than the pathology indicates: a retrospective analysis of qualitative and quantitative buffy coat CMV-PCR, renal biopsy pathology and tissue CMV-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01413.X

Cytomegalovirus disease after prophylaxis with oral ganciclovir in renal transplantation: the importance of HLA-DR matching

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01413.X

Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01413.X

10.1111/J.1600-6143.2006.01413.X

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference